Skip to main content

Turkish lira, Russia’s vaccine, virus cases in Hungary

The pressure on the Turkish lira this week as the risk of EU sanctions continued to rise has prompted a further tightening of monetary conditions, but an outright hike to policy rates at next week’s MPC meeting is highly unlikely. Meanwhile, the early results of Russia's coronavirus vaccine development suggest that the road to an effective vaccine will be long and bumpy. Finally, the rapid increase in coronavirus cases in Hungary increases the risk of a severe virus outbreak which would slow the pace of the recovery.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.